Dr Claude E Saint-jacques, MD | |
617 Old Symsonia Rd, Benton, KY 42025-5042 | |
(270) 527-2411 | |
(270) 527-8734 |
Full Name | Dr Claude E Saint-jacques |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 617 Old Symsonia Rd, Benton, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265482426 | NPI | - | NPPES |
000000496111 | Other | KY | BLUE CROSS AND BLUE SHIEL |
P00134537 | Other | KY | RR MEDICARE |
610601267 | Other | KY | COMMERCIAL |
64243256 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 24325 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Claude E Saint-jacques, MD 617 Old Symsonia Rd, Benton, KY 42025-5042 Ph: (270) 527-2411 | Dr Claude E Saint-jacques, MD 617 Old Symsonia Rd, Benton, KY 42025-5042 Ph: (270) 527-2411 |
News Archive
An advisory committee recommended today that the Food and Drug Administration (FDA) approve QAB149 (indacaterol) 75 mcg in the US as a once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Initial results from a Washington, D.C., campaign to have all residents tested for HIV show that HIV prevalence in the city is more than twice the nation's average, according to results released Tuesday during a meeting of the Mayor's Task Force on HIV and AIDS, the Washington Post reports.
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
A team of Duke University researchers and African colleagues will be studying strategies to curb the spread of malaria while protecting human and environmental health. The work in regions where the potentially deadly, mosquito-borne disease occurs will be supported by a $2.2 million, four-year grant from the U.S. National Institutes of Health.
Experts, gathered for the start of a four-day conference on HIV vaccines in Paris, called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.
› Verified 5 days ago